From a technical standpoint we are looking pretty strong as we closed about the 9-day AND the 26-day moving average with high buying pressure whicks which is interesting
Now from a company perspective standpoint we are most likely to first get approval on, this would be like the most expensive drug I have EVER heard of! In other words MEGA MEGA profit potential for APRE. So basically this would make more money per patient than any other drug in the ENTIRE cancer industry.